Lasom Supakanya, Komanasin Nantarat, Settasatian Nongnuch, Settasatian Chatri, Kukongviriyapan Upa, Intharapetch Pongsak
Biomedical Science Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand.
Cardiovascular Research Group, Khon Kaen University, Khon Kaen, Thailand.
J Res Med Sci. 2018 Jul 26;23:59. doi: 10.4103/jrms.JRMS_518_17. eCollection 2018.
The imbalance of von Willebrand factor (vWF) and a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13 (ADAMTS13) has been associated with atherosclerosis progression. A high level of vWF which regulates thrombus formation is associated with diabetes mellitus (DM), and some and polymorphisms have effects on their levels. Therefore, this study aimed to evaluate the associations of and polymorphisms and their levels with DM and severity of coronary stenosis.
Eighty-seven DM and 84 control individuals were recruited. vWF and ADAMTS13 activities as well as vWF antigen were measured by collagen-binding assay (CBA), residual-CBA, and in-house enzyme-linked immunosorbent assay, respectively. 3 and polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism.
The E and G alleles and AA genotype of Q448E, rs2073932, and rs652600, respectively, were independently associated with DM (odds ratio [OR] [95% confidence interval (CI)] = 2.5 [1.1, 5.6], 2.3 [1.0, 5.2], and 4.7 [1.2, 18.6], respectively). Moreover, E allele and AA genotype of Q448E and rs652600 were also significantly associated with multi-vessel disease (OR [95% CI] = 2.2 [1.0, 4.8] and 3.2 [1.0, 10.0], respectively), while the E and G allele of Q448E and rs2073932 were associated with high Gensini score (OR [95% CI] = 2.3 [1.1, 4.9] and 2.3 [1.1, 5.1], respectively).
Association of polymorphisms with DM, number of vessel stenosis, and Gensini score may indicate the possible contribution of polymorphisms to atherosclerosis progression and severity of coronary stenosis in DM.
血管性血友病因子(vWF)与含血小板反应蛋白基序的解聚素样金属蛋白酶13(ADAMTS13)之间的失衡与动脉粥样硬化进展有关。高水平的vWF可调节血栓形成,其与糖尿病(DM)相关,并且一些vWF基因多态性会影响其水平。因此,本研究旨在评估vWF基因多态性及其水平与DM及冠状动脉狭窄严重程度之间的关联。
招募了87例DM患者和84例对照个体。分别采用胶原结合试验(CBA)、残留CBA法和内部酶联免疫吸附试验检测vWF和ADAMTS13活性以及vWF抗原。通过聚合酶链反应-限制性片段长度多态性测定vWF基因Q448E位点rs2073932和rs652600的多态性。
vWF基因Q448E位点rs2073932的E等位基因和G等位基因以及rs652600的AA基因型分别独立与DM相关(比值比[OR][95%置信区间(CI)]分别为2.5[1.1,5.6]、2.3[1.0,5.2]和4.7[1.2,18.6])。此外,Q448E位点rs652600的E等位基因和AA基因型也与多支血管病变显著相关(OR[95%CI]分别为2.2[1.0,4.8]和3.2[1.0,10.0]),而Q448E位点rs2073932的E和G等位基因与高Gensini评分相关(OR[95%CI]分别为2.3[1.1,4.9]和2.3[1. _,5.1])。
vWF基因多态性与DM、血管狭窄数量和Gensini评分之间的关联可能表明vWF基因多态性对DM患者动脉粥样硬化进展和冠状动脉狭窄严重程度可能有影响。